Debora Ledesma

7PUBLICATIONS
74CO-AUTHORS
Molecular targetsCancer diagnosisMedical mycologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

|May 08, 2024
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma.

Debora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia

|Mar 13, 2024
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides.

Mario L Marques-Piubelli, Jesus Navarrete, Debora A Ledesma

|Jun 10, 2023
Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD.

Jessica I Sanchez, Edwin R Parra, Jingjing Jiao

|Nov 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.

Yifan Zhou, Yusra B Medik, Bhakti Patel

|Oct 08, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy.

Riyad N H Seervai, Woo Cheal Cho, Emily Y Chu

Pageof 2

Frequent Collaborators

4 joint publications

Carlos Torres-Cabala

3 joint publications

Courtney W Hudgens

3 joint publications

Mario L Marques-Piubelli

2 joint publications

Phyu P Aung